Use of a cell permeable peptide (TAT-SNAG), predicted to interfere with SNAI2 protein-protein interactions mediated by the SNAG domain, was also able to impair AML cell growth and colony formation as well as synergize with Cytarabine treatment in vitro to induce AML cell death. Here, SNAI2 is linked to acute myeloid leukemia.